$968 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 64 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 40.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NBIX | Sell | NEUROCRINE BIOSCIENC | $46,005,000 | -29.5% | 1,012,206 | -38.7% | 4.75% | +50.6% |
| MRK | Sell | MERCK & CO INC | $42,802,000 | +7.9% | 742,960 | -0.9% | 4.42% | +130.4% |
| PFE | New | PFIZER INC | $41,982,000 | – | 1,192,330 | +100.0% | 4.34% | – |
| LLY | Buy | ELI LILLY & CO | $41,730,000 | +14.4% | 529,908 | +4.6% | 4.31% | +144.3% |
| CELG | Sell | CELGENE CORP | $41,100,000 | -72.6% | 416,704 | -72.2% | 4.24% | -41.5% |
| GILD | Sell | GILEAD SCIENCES INC | $39,716,000 | -73.4% | 476,102 | -70.7% | 4.10% | -43.2% |
| NXTM | Buy | NXSTAGE MEDICAL | $39,644,000 | +60.5% | 1,828,582 | +11.0% | 4.09% | +242.9% |
| BMRN | Sell | BIOMARIN PHARMAC INC | $38,498,000 | -68.7% | 494,836 | -66.8% | 3.98% | -33.1% |
| MDT | Sell | MEDTRONIC PLC | $36,906,000 | +3.4% | 425,333 | -10.6% | 3.81% | +120.8% |
| ABMD | Buy | ABIOMED INC | $32,605,000 | +541.6% | 298,338 | +456.6% | 3.37% | +1268.7% |
| ADPTQ | Buy | ADEPTUS HEALTH INCcl a | $31,983,000 | +29.5% | 619,108 | +39.2% | 3.30% | +176.6% |
| DXCM | Sell | DEXCOM INC | $31,293,000 | -19.4% | 394,466 | -31.0% | 3.23% | +72.1% |
| TEVA | Buy | TEVA PHARMACEUTICALadr | $30,938,000 | +13.6% | 615,935 | +21.0% | 3.20% | +142.6% |
| ALXN | Sell | ALEXION PHARM INC | $29,347,000 | -67.9% | 251,348 | -61.7% | 3.03% | -31.5% |
| PTLA | Sell | PORTOLA PHARMACEUTIC | $29,013,000 | -10.7% | 1,229,382 | -22.8% | 3.00% | +90.7% |
| SHPG | Sell | SHIRE PLCsp adr | $27,322,000 | -60.8% | 148,424 | -63.4% | 2.82% | -16.3% |
| ACHC | Buy | ACADIA HEALTHCARE | $26,626,000 | +15.4% | 480,605 | +14.8% | 2.75% | +146.3% |
| FOLD | Sell | AMICUS THERAPEUTICS | $26,147,000 | -66.5% | 4,788,738 | -48.1% | 2.70% | -28.4% |
| TDOC | Buy | TELADOC INC | $23,457,000 | +150.5% | 1,464,221 | +50.1% | 2.42% | +434.7% |
| UNH | Sell | UNITEDHEALTH GRP INC | $20,487,000 | -9.5% | 145,095 | -17.4% | 2.12% | +93.3% |
| VRTX | Sell | VERTEX PHARMACEUTICL | $19,920,000 | -72.0% | 231,575 | -74.2% | 2.06% | -40.3% |
| INCY | Sell | INCYTE CORPORATION | $19,872,000 | -76.2% | 248,459 | -78.5% | 2.05% | -49.2% |
| ALGN | Sell | ALIGN TECH INC | $19,826,000 | -35.4% | 246,127 | -41.7% | 2.05% | +37.8% |
| XLRN | Sell | ACCELERON PHARMA | $17,748,000 | -53.2% | 522,294 | -63.7% | 1.83% | -0.1% |
| MYL | Sell | MYLAN N V | $17,649,000 | -35.4% | 408,170 | -30.8% | 1.82% | +37.9% |
| GBT | New | GLOBAL BLOOD THERA | $16,378,000 | – | 987,224 | +100.0% | 1.69% | – |
| SGNT | Sell | SAGENT PHARMACEUTI | $15,104,000 | -17.3% | 1,008,265 | -32.8% | 1.56% | +76.7% |
| ALDR | Sell | ALDER BIOPHARMACEU | $13,115,000 | -58.5% | 525,221 | -59.3% | 1.35% | -11.4% |
| ISRG | Sell | INTUITIVE SURGIC INC | $12,748,000 | -9.2% | 19,274 | -17.5% | 1.32% | +93.8% |
| NVO | NOVO-NORDISK ASadr | $11,626,000 | -0.8% | 216,175 | 0.0% | 1.20% | +112.2% | |
| NUVA | NUVASIVE INC | $9,931,000 | +22.8% | 166,300 | 0.0% | 1.02% | +162.1% | |
| ICPT | Sell | INTERCEPT PHARMACE | $7,798,000 | -75.3% | 54,651 | -77.7% | 0.80% | -47.2% |
| MOH | Buy | MOLINA HEALTHCARE | $7,630,000 | +46.1% | 152,900 | +88.8% | 0.79% | +211.5% |
| OPHT | Sell | OPHTHOTECH CORP | $7,491,000 | -50.4% | 146,800 | -58.9% | 0.77% | +6.0% |
| AMSG | AMSURG CORP | $7,475,000 | +3.9% | 96,400 | 0.0% | 0.77% | +121.8% | |
| TMH | Sell | TEAM HEALTH HLDGS | $7,154,000 | -36.4% | 175,900 | -34.6% | 0.74% | +35.8% |
| NVAX | Buy | NOVAVAX INC | $6,632,000 | +211.5% | 912,305 | +121.2% | 0.68% | +565.0% |
| WMGI | Buy | WRIGHT MED GROUP N V | $6,374,000 | +111.1% | 366,975 | +101.7% | 0.66% | +350.7% |
| MNTA | Sell | MOMENTA PHARMACEUTIC | $6,200,000 | -1.4% | 574,040 | -15.7% | 0.64% | +110.5% |
| PRTA | Sell | PROTHENA CORP PLC | $6,109,000 | -62.7% | 174,746 | -56.1% | 0.63% | -20.3% |
| IART | INTEGRA LIFESCIENCE | $4,831,000 | +18.4% | 60,560 | 0.0% | 0.50% | +153.3% | |
| SCAI | Buy | SURGICAL CARE AFFI | $4,686,000 | +27.5% | 98,300 | +23.8% | 0.48% | +171.9% |
| PTCT | Sell | PTC THERAPEUTICS I | $4,556,000 | -72.9% | 648,976 | -75.2% | 0.47% | -42.3% |
| ARAY | Buy | ACCURAY INC | $4,286,000 | -3.9% | 825,875 | +7.0% | 0.44% | +105.1% |
| ADXS | Sell | ADVAXIS INC | $3,510,000 | -82.1% | 433,859 | -80.0% | 0.36% | -61.9% |
| COLL | COLLEGIUM PHARMACEUT | $3,489,000 | -34.7% | 294,400 | 0.0% | 0.36% | +39.5% | |
| RGNX | Sell | REGENXBIO INC | $3,379,000 | -54.0% | 367,541 | -46.0% | 0.35% | -1.7% |
| ENTL | Sell | ENTELLUS MED INC | $2,668,000 | -2.0% | 146,006 | -2.4% | 0.28% | +108.3% |
| QURE | Sell | UNIQURE N.V. | $2,559,000 | -84.9% | 347,271 | -75.7% | 0.26% | -67.8% |
| XENT | Buy | INTERSECT ENT INC | $2,497,000 | +13.8% | 193,140 | +67.2% | 0.26% | +143.4% |
| LCI | Sell | LANNETT CO INC | $2,443,000 | +4.8% | 102,693 | -21.0% | 0.25% | +123.0% |
| New | NEURODERM LTD | $1,706,000 | – | 104,971 | +100.0% | 0.18% | – | |
| RDY | Sell | DR REDDYS LABS LTDadr | $1,647,000 | -60.4% | 32,155 | -65.1% | 0.17% | -15.4% |
| SAGE | Sell | SAGE THERAPEUTICS | $1,574,000 | -88.3% | 52,250 | -87.6% | 0.16% | -75.0% |
| AERI | New | AERIE PHARMACEUTIC | $1,556,000 | – | 88,400 | +100.0% | 0.16% | – |
| AGIO | New | AGIOS PHARMACEUTIC | $1,512,000 | – | 36,100 | +100.0% | 0.16% | – |
| NTLA | New | INTELLIA THERAPEUT | $1,466,000 | – | 123,159 | +100.0% | 0.15% | – |
| DNAI | Sell | PRONAI THERAPEUTICS | $1,359,000 | -82.3% | 201,660 | -82.3% | 0.14% | -62.3% |
| AVXS | Sell | AVEXIS INC | $976,000 | -88.0% | 25,672 | -91.4% | 0.10% | -74.2% |
| ACAD | Sell | ACADIA PHARMACEUTCLS | $960,000 | -95.0% | 29,582 | -95.7% | 0.10% | -89.4% |
| CBPO | CHINA BIOLOGIC PROD | $626,000 | -7.1% | 5,890 | 0.0% | 0.06% | +97.0% | |
| PRFMF | Sell | PROFOUND MEDICAL | $605,000 | -34.0% | 541,500 | -47.5% | 0.06% | +40.9% |
| MCRB | New | SERES THERAPEUTICS | $598,000 | – | 20,600 | +100.0% | 0.06% | – |
| ALNY | New | ALNYLAM PHARMACUETCL | $555,000 | – | 10,000 | +100.0% | 0.06% | – |
| IRWD | Exit | IRONWOOD PHARMACEUCL | $0 | – | -10,725 | -100.0% | -0.01% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -12,760 | -100.0% | -0.01% | – |
| AMPH | Exit | AMPHASTAR PHARMACTLS | $0 | – | -38,905 | -100.0% | -0.02% | – |
| ASND | Exit | ASCENDIS PHARMA A Ssp adr | $0 | – | -31,100 | -100.0% | -0.03% | – |
| AKRXQ | Exit | AKORN INC | $0 | – | -33,744 | -100.0% | -0.04% | – |
| Exit | PRONAI THERAPEUTICS | $0 | – | -201,660 | -100.0% | -0.07% | – | |
| MNKKQ | Exit | MALLINCKRODT PLC | $0 | – | -27,467 | -100.0% | -0.08% | – |
| PRGO | Exit | PERRIGO CO | $0 | – | -17,030 | -100.0% | -0.10% | – |
| TNDM | Exit | TANDEM DIABETES CA | $0 | – | -268,690 | -100.0% | -0.11% | – |
| ANAC | Exit | ANACOR PHARMACEUTI | $0 | – | -46,500 | -100.0% | -0.12% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -10,631 | -100.0% | -0.14% | – |
| PRAH | Exit | PRA HEALTH SCIENCE | $0 | – | -97,800 | -100.0% | -0.20% | – |
| CARA | Exit | CARA THERAPEUTICS | $0 | – | -1,212,578 | -100.0% | -0.36% | – |
| NVS | Exit | NOVARTIS AGsp adr | $0 | – | -123,805 | -100.0% | -0.43% | – |
| EW | Exit | EDWARDS LIFESCIENCE | $0 | – | -110,541 | -100.0% | -0.47% | – |
| IMDZ | Exit | IMMUNE DESIGN CORP | $0 | – | -856,867 | -100.0% | -0.54% | – |
| TGTX | Exit | TG THERAPEUTICS | $0 | – | -1,521,667 | -100.0% | -0.63% | – |
| AIMT | Exit | AIMMUNE THERAPEUTICS | $0 | – | -982,133 | -100.0% | -0.64% | – |
| IONS | Exit | IONIS PHARMACEUTICAL | $0 | – | -433,300 | -100.0% | -0.85% | – |
| STJ | Exit | ST JUDE MEDICAL INC | $0 | – | -334,584 | -100.0% | -0.89% | – |
| TSRO | Exit | TESARO INC | $0 | – | -689,869 | -100.0% | -1.47% | – |
| TMO | Exit | THERMO FISHER SCI | $0 | – | -370,376 | -100.0% | -2.54% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -234,572 | -100.0% | -2.95% | – |
| REGN | Exit | REGENERON PHARMCTCLS | $0 | – | -232,770 | -100.0% | -4.06% | – |
| AMGN | Exit | AMGEN INC | $0 | – | -682,797 | -100.0% | -4.95% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.